123 related articles for article (PubMed ID: 38932134)
1. Safety and Immunogenicity of the Live Attenuated Varicella Vaccine in Vietnamese Children Aged 12 Months to 12 Years: An Open-Label, Single-Arm Bridging Study.
Hung PV; Giang LTH; Toi PL; Thuc VTM; Anh BDT; Pho DC; Hung PN
Viruses; 2024 May; 16(6):. PubMed ID: 38932134
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.
Mitra M; Faridi M; Ghosh A; Shah N; Shah R; Chaterjee S; Narang M; Bhattacharya N; Bhat G; Choudhury H; Kadhe G; Mane A; Roy S
Hum Vaccin Immunother; 2015; 11(2):443-9. PubMed ID: 25692656
[TBL] [Abstract][Full Text] [Related]
3. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents.
Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Wittke F; Jotterand V
Hum Vaccin Immunother; 2021 Nov; 17(11):4183-4189. PubMed ID: 34702124
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial.
Hao B; Chen Z; Zeng G; Huang L; Luan C; Xie Z; Chen J; Bao M; Tian X; Xu B; Wang Y; Wu J; Xia S; Yuan L; Huang J
Clin Microbiol Infect; 2019 Aug; 25(8):1026-1031. PubMed ID: 30616012
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
Ramkissoon A; Coovadia HM; Jugnundan P; Haffejee IE; Meurice F; Vandevoorde D
S Afr Med J; 1995 Dec; 85(12):1295-8. PubMed ID: 8600589
[TBL] [Abstract][Full Text] [Related]
6. Safety of a second dose of varicella vaccine administered at 4 to 6 years of age in healthy children in Argentina.
Fridman D; Monti A; Bonnet MC; Armoni J; Stamboulian D
Hum Vaccin; 2011 Oct; 7(10):1066-71. PubMed ID: 21989288
[TBL] [Abstract][Full Text] [Related]
7. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults.
Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Banniettis N
Hum Vaccin Immunother; 2021 Nov; 17(11):4177-4182. PubMed ID: 34473594
[TBL] [Abstract][Full Text] [Related]
8. Short-term immunogenicity and safety of hepatitis-A and varicella vaccines in HIV-exposed uninfected and HIV-unexposed South African children.
Mutsaerts EAML; Nunes MC; Bhikha S; Ikulinda BT; Jose L; Koen A; Moultrie A; Grobbee DE; Klipstein-Grobusch K; Weinberg A; Madhi SA
Vaccine; 2020 May; 38(22):3862-3868. PubMed ID: 32307279
[TBL] [Abstract][Full Text] [Related]
9. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
10. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
Ozaki T
Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of live attenuated varicella vaccine in 9-month-old children.
Kanra G; Ceyhan M; Ozmert E
Pediatr Int; 2000 Dec; 42(6):674-7. PubMed ID: 11192526
[TBL] [Abstract][Full Text] [Related]
14. [Safety and immunogenicity of lyophilized live attenuated domestic varicella vaccine].
Chen EF; Jiang ZG; Li Q
Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):435-7. PubMed ID: 20084971
[TBL] [Abstract][Full Text] [Related]
15. Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis.
Kreth HW; Hoeger PH;
Eur J Pediatr; 2006 Oct; 165(10):677-83. PubMed ID: 16835758
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.
Shinefield HR; Black SB; Staehle BO; Matthews H; Adelman T; Ensor K; Li S; Chan I; Heyse J; Waters M; Chan CY; Vessey SJ; Kaplan KM; Kuter BJ;
Pediatr Infect Dis J; 2002 Jun; 21(6):555-61. PubMed ID: 12182381
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.
Sasadeusz J; Prince HM; Schwarer A; Szer J; Stork A; Bock HL; Povey M; Nicholson O; Innis BL
Transpl Infect Dis; 2014 Dec; 16(6):1024-31. PubMed ID: 25272081
[TBL] [Abstract][Full Text] [Related]
18. Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial.
Huang L; Chen Z; Hu Y; Xie Z; Qiu P; Zhu L; Bao M; Quan Y; Zeng J; Wang Y; Cui X; Yuan L; Xia S; Meng F
Hum Vaccin Immunother; 2019; 15(4):822-827. PubMed ID: 30481106
[TBL] [Abstract][Full Text] [Related]
19. Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial.
Prymula R; Simko R; Povey M; Kulcsar A
BMC Pediatr; 2016 Jan; 16():7. PubMed ID: 26762528
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a single dose of a live attenuated Japanese encephalitis chimeric virus vaccine in Vietnam: A single-arm, single-center study.
Vu TD; Nguyen QD; Tran HTA; Bosch-Castells V; Zocchetti C; Houillon G
Int J Infect Dis; 2018 Jan; 66():137-142. PubMed ID: 29081368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
